查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2078874

腦下垂體癌市場：依癌症類型、荷爾蒙類型、治療方法、年齡層、最終使用者和地區分類。

Pituitary Cancer Market, By Cancer Type, By Hormone Type, By Treatment Type, By Age Group, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

腦下垂體癌市場預計在 2026 年達到 5.025 億美元，預計到 2033 年將達到 9.669 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 9.8%。

分析範圍 分析詳情
基準年 2025 市場規模（2026 年） 5.025億美元
效能數據 2020-2024 預測期 2026-2033
預測期（2026-2033 年）複合年成長率 9.80% 預計金額（2033 年） 9.669億美元

腦下垂體癌的病因尚未完全明確。然而，遺傳因素和荷爾蒙失衡可能與之相關。大多數腦下垂體腫瘤是腺瘤，屬於良性腫瘤。腺瘤的發生率低於腦下垂體囊腫，後者也屬於良性腫瘤。

腦下垂體癌的常見症狀包括頭痛、視力改變、體重減輕或增重困難以及記憶力和注意力下降。根據腦下垂體腫瘤的類型，它可能會分泌過多的激素，導致庫欣氏症候群。在某些情況下，庫欣氏症候群會導致催乳素分泌過多，進而引起胸部和手臂皮膚變薄，以及腿部和腳部骨骼脆弱。另一種表現形式是即使未懷孕也會出現乳汁分泌。此外，庫欣氏症候群還會導致血壓出現各種變化，並可能表現為臉部潮紅以及四肢血壓升高。

市場動態：

腦下垂體腫瘤發生率的上升、研發投入的增加以及治療技術的進步預計將推動全球腦下垂體癌市場在預測期內成長。此外，公眾意識的提高也促進了對非侵入性治療的需求。提供腦下垂體腫瘤專科服務的醫院和診所數量的增加也推動了市場成長。

然而，癌症治療的高成本預計將成為預測期內阻礙全球腦下垂體癌市場成長的主要因素。

本報告的主要特點

  • 本報告揭示了各個細分市場的潛在商機，並描述了該市場中一系列有吸引力的投資提案。
  • 此外，它還提供了有關市場促進因素和限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要公司採取的競爭策略的重要見解。
  • 本節根據公司概況、產品系列、主要趨勢、財務表現和策略等各種參數，對全球腦下垂體癌市場的主要公司進行介紹。
  • 本報告中的見解將使負責人和企業經營團隊能夠就未來的產品發布、技術更新、市場擴張和行銷策略做出明智的決策。
  • 《全球腦下垂體癌市場》報告面向該行業的眾多相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過分析全球腦下垂體癌市場中使用的各種策略矩陣來促進決策。

目錄

第1章：分析目標與假設

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
      • 發病率和盛行率增加
      • 醫學影像診斷技術的進步
      • 擴大研發
      • 對個人化醫療的需求日益成長
    • 抑制因子
      • 認知度低和診斷延遲
      • 缺乏標準化的治療指南
      • 對於侵襲性極強的腦下垂體癌，治療選擇有限。
      • 藥物研發面臨的挑戰
    • 機會
      • 標靶治療的研發
      • 聯合治療
      • 外科技術的進步
      • 新型成像技術的發展
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特五力分析
  • 企業合併情景

第4章：腦下垂體癌

  • 供給面和需求面分析
  • 經濟影響

第5章：腦下垂體癌市場：依癌症類型分類（2021-2033 年）

  • 腦下垂體腺瘤（良性腫瘤）
  • 腦下垂體瘤（惡性腫瘤）

第6章：腦下垂體癌市場：依荷爾蒙類型分類（2021-2033 年）

  • 泌乳素瘤
  • 生長激素分泌腫瘤（肢端肥大症）
  • 促腎上腺皮質激素分泌腫瘤（庫欣氏症）
  • 甲狀腺刺激素分泌腫瘤（TSH瘤）
  • 促性腺激素分泌腫瘤

第7章 腦下垂體癌市場：依治療方法分類（2021-2033 年）

  • 外科手術
  • 放射線治療
  • 藥物治療（例如，多巴胺促效劑、生長抑制素類似物、荷爾蒙補充療法）
  • 標靶治療
  • 化療

第8章 腦下垂體癌市場：依年齡層分類（2021-2033 年）

  • 兒童
  • 成人

第9章 腦下垂體癌市場：依最終使用者分類（2021-2033 年）

  • 醫院
  • 專科診所
  • 癌症治療中心
  • 研究機構

第10章 腦下垂體癌市場：依地區分類（2021-2033 年）

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • GCC
    • 以色列
    • 北非
    • 中非
    • 其他中東和非洲國家

第11章 競爭格局

  • Novartis International AG
  • Pfizer Inc.
  • Ipsen Biopharmaceuticals, Inc.
  • Endocyte
  • RECORDATI GROUP
  • Camurus AB
  • Endeavor Biomedicines, Inc
  • Debiopharm International SA

第12章

  • 分析方法
  • 關於 Coherent Market Insights
簡介目錄
Product Code: CMI5851

Pituitary Cancer Market is estimated to be valued at USD 502.5 Mn in 2026 and is expected to reach USD 966.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 502.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 9.80% 2033 Value Projection: USD 966.9 Mn

The cause of pituitary cancer is not well understood. But genetics and hormonal imbalances may play a role. Most pituitary tumors are adenomas, or noncancerous. They are not as common as pituitary gland cysts, which are benign (noncancerous).

Symptoms of pituitary cancer often include headaches, vision changes, loss of weight or an inability to gain weight, and trouble with memory and concentration. Some types of pituitary tumors release too many hormones, which can lead to a disease called Cushing's syndrome. In some cases, this disease causes the body to produce too much prolactin, which can cause thinning of the skin in the chest and arms, and weak bones in the legs and feet. Other forms of this condition can cause the breasts to make milk, even when the person is not pregnant. The condition can also cause a wide range of changes in blood pressure, including a flushed face and high blood pressure in the arms or legs.

Market Dynamics:

Rising incidences of pituitary tumors, increasing investments in research and development activities, and technological advancements in treatment methods are expected to drive growth of the global pituitary cancer market during the forecast period. In addition, increased awareness among the populace has led to a higher demand for noninvasive treatments. The market is also driven by a rise in the number of hospitals and clinics that offer specialized services for pituitary tumors.

However, the high cost of cancer treatments is a major factor expected to impede the growth of the global pituitary cancer market over the forecast period.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pituitary cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novartis International AG, Pfizer Inc., Ipsen Biopharmaceuticals, Inc., Endocyte, RECORDATI GROUP, Camurus AB, Endeavor Biomedicines, Inc., and Debiopharm International SA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pituitary cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pituitary cancer market

Global Pituitary Cancer Market Detailed Segmentation:

  • By Cancer Type:
  • Pituitary Adenoma (Benign Tumor)
  • Pituitary Carcinoma (Malignant Tumor)
  • By Hormone Type:
  • Prolactinoma
  • Growth Hormone-Secreting Tumor (Acromegaly)
  • Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
  • Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
  • Gonadotropin-Secreting Tumor
  • By Treatment Type:
  • Surgery
  • Radiation Therapy
  • Medications (e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
  • Targeted Therapy
  • Chemotherapy
  • By Age Group:
  • Pediatric
  • Adult
  • By End User:
  • Hospitals
  • Specialty Clinics
  • Cancer Treatment Centers
  • Research Institutes
  • By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
  • Company Profile:
  • Novartis International AG
  • Pfizer Inc.
  • Ipsen Biopharmaceuticals, Inc.
  • Endocyte
  • RECORDATI GROUP
  • Camurus AB
  • Endeavor Biomedicines, Inc.
  • Debiopharm International SA

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Pituitary Cancer, By Cancer Type
    • Market Pituitary Cancer, By Hormone Type
    • Market Pituitary Cancer, By Treatment Type
    • Market Pituitary Cancer, By Age Group
    • Market Pituitary Cancer, By End User
    • Market Pituitary Cancer, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
      • Increasing Incidence and Prevalence
      • Advancements in Medical Imaging and Diagnostics
      • Increased Research and Development
      • Growing Demand for Personalized Medicine
    • Restraints
      • Limited Awareness and Delayed Diagnosis
      • Lack of Standardized Treatment Guidelines
      • Limited Treatment Options for Aggressive Pituitary Cancers
      • Challenges in Drug Development
    • Opportunities
      • Development of Targeted Therapies
      • Combination Therapies
      • Advancements in Surgical Techniques
      • Development of Novel Imaging Modalities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER€(TM)s Analysis
  • Merger and Acquisition Scenario

4. Pituitary Cancer

  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Pituitary Cancer Market , By Cancer Type, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022€"2033
    • Segment Trends
  • Pituitary Adenoma (Benign Tumor)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
  • Pituitary Carcinoma (Malignant Tumor)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Pituitary Cancer Market , By Hormone Type, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022€"2033
    • Segment Trends
  • Prolactinoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  • Growth Hormone-Secreting Tumor (Acromegaly)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  • Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  • Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  • Gonadotropin-Secreting Tumor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)

7. Pituitary Cancer Market , By Treatment Type, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023and 2033 (%)
    • Y-o-Y Growth Analysis, 2022€" 2033
    • Segment Trends
  • Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  • Radiation Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  • Medications(e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  • Targeted Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  • Chemotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)

8. Pituitary Cancer Market , By Age Group, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023and 2033 (%)
    • Y-o-Y Growth Analysis, 2022€"2033
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)

9. Pituitary Cancer Market , By End User, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023and 2033 (%)
    • Y-o-Y Growth Analysis, 2022€"2033
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  • Cancer Treatment Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)

10. Pituitary Cancer Market , By Region, 2021 - 2033, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023and 2033 (%)
    • Y-o-Y Growth Analysis, For Country 2022€"2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
      • GCC
      • Israel
      • North Africa
      • Central Africa
      • Rest of Middle East & Africa

11. Competitive Landscape

  • Novartis International AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ipsen Biopharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Endocyte
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • RECORDATI GROUP
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Camurus AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Endeavor Biomedicines, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Debiopharm International SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

12. Section

  • Research Methodology
  • About us